DXR: daxor.com Market Price to Net Income Ratio

Symbol and logo of brand Daxor Corp (DXR)

Daxor Corporation (DXR) focuses on creating benchmark blood volume assessment systems for intensivists and cardiac surgeons, maintaining a dominant position in its niche. Management aims to integrate these methods into standard treatment protocols through physician training. This daily price chart for the company on the GURU.Markets platform shows a P/E multiple of 8.00, while the uniqueness of its patents is balanced against clinic budget constraints.

daxor.com (DXR) P/E Multiple: for the period 09/25/2023 - 11/15/2026

Analytical breakdowns for Daxor Corporation

- market value and analyst target forecast:
Market Chart Daxor|DXR - Consensus Target
- market capitalization information:
Market Value Daxor Corp|DXR - Enterprise Value
- book capitalization indicators:
Net Assets per Share Daxor|DXR - Book Capitalization|Market Cap to Net Assets Ratio daxor.com|DXR - Cumulative Company Assets
- debt and solvency information:
All Debt to Shareholders' Equity Ratio Daxor Corporation|DXR - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Daxor Corporation|DXR - Company Aggregate Debts|Debts to Book Value Daxor Corp|DXR - Company Long-Term Debts|Company Short-Term Indebtedness Daxor|Interim Coverage Ratio daxor.com
- earnings and market multiples details:
DXR - Net Profit|Future Profit Daxor Corporation|DXR - P/E Multiple|Forward P/E Multiple daxor.com|DXR - Price/Earnings to Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Daxor Corporation|DXR - Operating profit before deduction of amortization|Earnings per share for the trailing year Daxor|DXR - Net earnings per share (EPS TTM)|Earnings per share growth in annualized terms for the last twelve months daxor.com|DXR - Earnings per share growth in current year|Net earnings per one share growth forecast for next year Daxor Corporation
- company sales and revenue statistics:
DXR - Company Sales|Projected Sales Volume Daxor Corporation|DXR - P/S Multiple|Market Cap to Expected Sales Ratio Daxor Corp.
Summary company analysis:DXR (Daxor)
Flagship merchandise of Daxor Corporation

The P/E ratio reflects the business value relative to its annual net income, allowing investors to assess the investment payback period and the degree to which an asset is overbought. By analyzing the forward P/E of Daxor Corporation (DXR), one can compare the market value of Daxor Corporation with the efficiency of its R&D developments in precision blood volume measurement, which is critical for evaluating capitalization within the high-tech med-tech sector.

Key competitors

Abbott Laboratories Inc. (ABT) - Business Payback Period|Price to Earnings Ratio TMO (Thermo Fisher)|Business Payback Period GE HealthCare|P/E Multiple MTD (mt.com)|Business Payback Period Waters Corporation (WAT)|Bio-Techne Corp - P/E Multiple|Business Payback Period Bruker BRKR|AZTA: P/E Multiple|Price to Earnings Ratio Varex Imaging|Price to Earnings Ratio SMLR|BFLY: Company Value to Net Income|Price to Earnings Ratio Mesa Laboratories Inc (MLAB)|QSI - Market Cap to Earnings|P/E Multiple NNOX (nanox.vision)|Quanterix Corp (QTRX) - Market Cap to Earnings|908 Devices - P/E Multiple|capsovision.com (CV) - Price to Earnings Ratio|MXCT: P/E Multiple|RPID - Business Payback Period|SEER (Seer Bio) - P/E Multiple|Price to Earnings Ratio Hyperfine Corp (HYPR)|P/E Multiple FONR|P/E Multiple Spectral AI Inc. (MDAI)|Price to Earnings Ratio Organovo VIVS|Aclarion Corp - Price to Earnings Ratio|AKYA: Price to Earnings Ratio|Company Value to Net Income THMO (ThermoGenesis Holdings Inc.)|TLIS: P/E Multiple|Market Cap to Earnings t2biosystems.com (TTOO)